Showing results (501-510 of 539) with videos related to

Sort By:
Pageof 54
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2020
Chemotherapy and COVID-19 Outcomes in Patients With CancerJustin Jee, Michael B Foote, Melissa Lumish, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 7, 2018
CD34+ Cell Selection versus Reduced-Intensity Conditioning and Unmodified Grafts for Allogeneic Hematopoietic Cell Transplantation in Patients Age >50 Years with Acute Myelogenous Leukemia and Myelodysplastic SyndromePere Barba, Rodrigo Martino, Qin Zhou, et al.
CBE Life Sciences Education|December 20, 2024
Cisnormative Language and Erasure of Trans* and Genderqueer Student Representation in Biology Education ResearchKaitlyn Coburn, Kris Troy, Carly A Busch, et al.
Blood Advances|July 23, 2021
Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformationOscar B Lahoud, Sean M Devlin, Molly A Maloy, et al.
Transplantation and Cellular Therapy|March 30, 2021
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell TherapyMarta Garcia-Recio, Kitsada Wudhikarn, Martina Pennisi, et al.
Advances in Cell and Gene Therapy|November 7, 2022
Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34+-selected allogeneic transplantationChristina Cho, Patrick Hilden, Scott T Avecilla, et al.
Bone Marrow Transplantation|April 28, 2022
Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplantMaria Sola, Valkal Bhatt, Meighan Palazzo, et al.
Bone Marrow Transplantation|October 10, 2017
Long-term prognosis for 1-year relapse-free survivors of CD34+ cell-selected allogeneic hematopoietic stem cell transplantation: a landmark analysisC Cho, M Hsu, P Barba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 30, 2016
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell TransplantationPere Barba, Ravin Ratan, Christina Cho, et al.
Blood Advances|February 22, 2020
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for managementMartina Pennisi, Tania Jain, Bianca D Santomasso, et al.
Pageof 54